Development of PMA guidance for ventricular assist devices and total artificial heart

The US Food and Drug Administration's (FDA's) involvement in the investigation of devices since 1980 is discussed. The development of draft guidelines for a premarket approval application (PMA) is described. The availability of the document is announced and comments are solicited.<
>